Wall Street rebounds; biotech shares snap losing streak

By Angela Moon NEW YORK (Reuters) – U.S. stocks ended higher on Tuesday, rebounding from a two-day decline as the hard-hit biotechnology sector regained its momentum and a strong read on consumer confidence increased optimism about the economy. Trading was choppy throughout the day with the Nasdaq at one point turning lower, led by a sharp reversal in biotech shares. .So-called momentum stocks were still down for the day but off their lows, including Netflix , down 2.1 percent at $370.84. Netflix has declined for 14 of the past 15 sessions, falling almost 19 percent over that stretch Biotech shares also reversed earlier losses, including Regeneron Pharma , ending 0.8 percent higher at $308.87, and Gilead Sciences Inc , up 1.3 percent at $73.03.